Figure 1
From: Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis
Treatment flowchart for patients with portal vein thrombosis. The choice of treatment for portal vein thrombosis was determined by the physician in charge after a comprehensive evaluation of the patient's background and other factors. Of the 76 patients with portal vein thrombosis in the setting of cirrhosis, 61 were included after excluding those treated with danaparoid sodium or antithrombin III. Edoxaban and warfarin were administered to 43 and 18 patients, respectively. One patient who used warfarin was excluded because he discontinued treatment owing to drug-induced liver injury.
